Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001232119 | SCV001404665 | pathogenic | Familial hemiplegic migraine | 2022-10-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu825*) in the ATP1A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATP1A2 are known to be pathogenic (PMID: 30690204). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ATP1A2-related conditions. ClinVar contains an entry for this variant (Variation ID: 958871). For these reasons, this variant has been classified as Pathogenic. |